Logo image of NCNO

NCINO INC (NCNO) Stock Fundamental Analysis

NASDAQ:NCNO - Nasdaq - US63947X1019 - Common Stock - Currency: USD

26.99  -0.48 (-1.75%)

After market: 26.99 0 (0%)

Fundamental Rating

3

Overall NCNO gets a fundamental rating of 3 out of 10. We evaluated NCNO against 284 industry peers in the Software industry. The financial health of NCNO is average, but there are quite some concerns on its profitability. While showing a medium growth rate, NCNO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NCNO had positive earnings in the past year.
NCNO had a positive operating cash flow in the past year.
NCNO had negative earnings in each of the past 5 years.
In multiple years NCNO reported negative operating cash flow during the last 5 years.
NCNO Yearly Net Income VS EBIT VS OCF VS FCFNCNO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.78%, NCNO is in the better half of the industry, outperforming 60.92% of the companies in the same industry.
NCNO has a Return On Equity of -2.74%. This is in the better half of the industry: NCNO outperforms 63.03% of its industry peers.
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROIC N/A
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
NCNO Yearly ROA, ROE, ROICNCNO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

NCNO has a Gross Margin (60.05%) which is comparable to the rest of the industry.
NCNO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NCNO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
NCNO Yearly Profit, Operating, Gross MarginsNCNO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

NCNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NCNO has been increased compared to 1 year ago.
The number of shares outstanding for NCNO has been increased compared to 5 years ago.
NCNO has a worse debt/assets ratio than last year.
NCNO Yearly Shares OutstandingNCNO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NCNO Yearly Total Debt VS Total AssetsNCNO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.27 indicates that NCNO is not in any danger for bankruptcy at the moment.
NCNO has a Altman-Z score of 3.27. This is in the better half of the industry: NCNO outperforms 60.56% of its industry peers.
The Debt to FCF ratio of NCNO is 5.06, which is a neutral value as it means it would take NCNO, 5.06 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.06, NCNO perfoms like the industry average, outperforming 58.45% of the companies in the same industry.
A Debt/Equity ratio of 0.24 indicates that NCNO is not too dependend on debt financing.
NCNO has a Debt to Equity ratio (0.24) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Altman-Z 3.27
ROIC/WACCN/A
WACC11.08%
NCNO Yearly LT Debt VS Equity VS FCFNCNO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

NCNO has a Current Ratio of 1.05. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NCNO (1.05) is worse than 72.54% of its industry peers.
NCNO has a Quick Ratio of 1.05. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.05, NCNO is not doing good in the industry: 71.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
NCNO Yearly Current Assets VS Current LiabilitesNCNO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

5

3. Growth

3.1 Past

The earnings per share for NCNO have decreased by 0.00% in the last year.
Looking at the last year, NCNO shows a quite strong growth in Revenue. The Revenue has grown by 13.40% in the last year.
Measured over the past years, NCNO shows a very strong growth in Revenue. The Revenue has been growing by 31.37% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
Revenue 1Y (TTM)13.4%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.53%

3.2 Future

Based on estimates for the next years, NCNO will show a very strong growth in Earnings Per Share. The EPS will grow by 22.96% on average per year.
NCNO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.98% yearly.
EPS Next Y8.23%
EPS Next 2Y15.52%
EPS Next 3Y22.96%
EPS Next 5YN/A
Revenue Next Year7.54%
Revenue Next 2Y8.03%
Revenue Next 3Y8.98%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NCNO Yearly Revenue VS EstimatesNCNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
NCNO Yearly EPS VS EstimatesNCNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 42.84, NCNO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of NCNO indicates a somewhat cheap valuation: NCNO is cheaper than 63.03% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.31. NCNO is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 30.64, the valuation of NCNO can be described as expensive.
Based on the Price/Forward Earnings ratio, NCNO is valued a bit cheaper than the industry average as 61.27% of the companies are valued more expensively.
NCNO's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 42.84
Fwd PE 30.64
NCNO Price Earnings VS Forward Price EarningsNCNO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCNO is on the same level as its industry peers.
NCNO's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 60.28
EV/EBITDA 143.39
NCNO Per share dataNCNO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NCNO does not grow enough to justify the current Price/Earnings ratio.
NCNO's earnings are expected to grow with 22.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.2
PEG (5Y)N/A
EPS Next 2Y15.52%
EPS Next 3Y22.96%

0

5. Dividend

5.1 Amount

NCNO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NCINO INC

NASDAQ:NCNO (6/13/2025, 8:26:34 PM)

After market: 26.99 0 (0%)

26.99

-0.48 (-1.75%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)N/A N/A
Inst Owners103.23%
Inst Owner Change11.64%
Ins Owners2.25%
Ins Owner Change18.42%
Market Cap3.11B
Analysts71.3
Price Target30.75 (13.93%)
Short Float %11.57%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.26%
Min EPS beat(2)-36.6%
Max EPS beat(2)-1.92%
EPS beat(4)2
Avg EPS beat(4)-0.66%
Min EPS beat(4)-36.6%
Max EPS beat(4)28.46%
EPS beat(8)6
Avg EPS beat(8)20.37%
EPS beat(12)9
Avg EPS beat(12)17.38%
EPS beat(16)13
Avg EPS beat(16)21.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.6%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)0.4%
Revenue beat(4)1
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)0.4%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.52%
Revenue beat(16)7
Avg Revenue beat(16)0.4%
PT rev (1m)16.25%
PT rev (3m)-28.46%
EPS NQ rev (1m)-9.36%
EPS NQ rev (3m)-30.9%
EPS NY rev (1m)-0.38%
EPS NY rev (3m)-20.08%
Revenue NQ rev (1m)-0.81%
Revenue NQ rev (3m)-5.16%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)-5.69%
Valuation
Industry RankSector Rank
PE 42.84
Fwd PE 30.64
P/S 5.59
P/FCF 60.28
P/OCF 56.46
P/B 2.9
P/tB N/A
EV/EBITDA 143.39
EPS(TTM)0.63
EY2.33%
EPS(NY)0.88
Fwd EY3.26%
FCF(TTM)0.45
FCFY1.66%
OCF(TTM)0.48
OCFY1.77%
SpS4.83
BVpS9.31
TBVpS-1.47
PEG (NY)5.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.05%
FCFM 9.27%
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Debt/EBITDA 11.29
Cap/Depr 9.01%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion 239.84%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 3.27
F-Score5
WACC11.08%
ROIC/WACCN/A
Cap/Depr(3y)23.11%
Cap/Depr(5y)36.46%
Cap/Sales(3y)1.95%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
EPS Next Y8.23%
EPS Next 2Y15.52%
EPS Next 3Y22.96%
EPS Next 5YN/A
Revenue 1Y (TTM)13.4%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.53%
Revenue Next Year7.54%
Revenue Next 2Y8.03%
Revenue Next 3Y8.98%
Revenue Next 5YN/A
EBIT growth 1Y48.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.17%
EBIT Next 3Y25.04%
EBIT Next 5YN/A
FCF growth 1Y3539%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y275.44%
OCF growth 3YN/A
OCF growth 5YN/A